We are live on ! Find out more
ANGO icon

AngioDynamics

138 hedge funds and large institutions have $251M invested in AngioDynamics in 2024 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more call options, than puts

Call options by funds: $74K | Put options by funds: $31K

64% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 36

28% more capital invested

Capital invested by funds: $197M → $251M (+$54.4M)

0% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 20

1% less funds holding

Funds holding: 139138 (-1)

1.7% less ownership

Funds ownership: 81.18%79.48% (-1.7%)

Holders
138
Holders Change
-1
Holders Change %
-0.72%
% of All Funds
1.98%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
59
Reduced
36
Closed
20
Calls
$74K
Puts
$31K
Net Calls
+$43K
Net Calls Change
+$24K
Name Holding Trade Value Shares
Change
Change in
Stake
AWM
151
AE Wealth Management
Kansas
-$86.7K -14,335 Closed
GCM
152
Graham Capital Management
Connecticut
-$65.1K -10,766 Closed
PD
153
Point72 (DIFC)
United Arab Emirates
-$31.5K -5,206 Closed
GCM
154
Gladius Capital Management
Illinois
-$30.7K -5,080 Closed
IC
155
Innealta Capital
Texas
-$14.6K -2,415 Closed
Simplex Trading
156
Simplex Trading
Illinois
-$11.2K -1,547 Closed
MPWT
157
MassMutual Private Wealth & Trust
Connecticut
-$1.86K -308 Closed

ANGO Hedge Fund Activity: Q3 2024 in Review

138 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2024, worth a combined $251M — up 28% from $197M a quarter earlier.

Fund positioning in ANGO was balanced in Q3 2024: 20 funds opened new positions, 20 closed out, 59 added to existing stakes and 36 trimmed.

The largest buyer was Segall Bryant & Hamill, adding an estimated $3.87M. The largest seller was ExodusPoint Capital Management, cutting an estimated $6.89M.

  • 138 institutional investors held AngioDynamics (ANGO) as of Q3 2024, down from 139 in Q2 2024.
  • Funds reported $251M of AngioDynamics stock for Q3 2024, up 28% quarter-over-quarter.
  • 20 funds opened new AngioDynamics positions in Q3 2024 and 20 closed out, a net change of 0 holders.
  • The largest AngioDynamics buyer in Q3 2024 was Segall Bryant & Hamill, an estimated $3.87M added.
  • The largest AngioDynamics seller in Q3 2024 was ExodusPoint Capital Management, an estimated $6.89M sold.

Based on aggregated 13F filings for Q3 2024.